Clinical Trials · NCT01507389
Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 24
- Start date
- Mar 2006
- Locations
- 1 site, Poland
- Primary endpoint
- Area under the Curve (0-infinity)